← Back to Search

Immediate Intervention Group for Knee Arthritis

N/A
Waitlist Available
Led By Linda Li, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, months 3, 6, and 9

Summary

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, only 13% of patients meet the activity recommendation of 150 minutes or more per week. The primary goal of this randomized controlled trial is to assess the efficacy of a Fitbit Flex (a wireless physical activity tracking device) paired with a new application, plus a brief education session and telephone counselling by a physiotherapist (PT), to improve physical activity and reduce sedentary time in patients with knee osteoarthritis.

Eligible Conditions
  • Knee Arthritis
  • Rotator Cuff Arthropathy
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, months 3, 6, and 9
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, months 3, 6, and 9 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Time spent in Moderate to Vigorous Physical Activity (MVPA)
Secondary study objectives
Knee Injury and OA Outcome Score (KOOS)
Partners in Health Scale
The Patient Health Questionnaire-9 (PHQ-9)
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Immediate Intervention GroupActive Control1 Intervention
Education session, Fitbit/FitViz, PT counselling: Participants receive this intervention in Months 1-3. The session will include a presentation on physical activity, an individual goal-setting session with a registered physiotherapist, and an orientation to the Fitbit Flex and the FitViz app. In Months 1 and 2, participants will use the Fitbit/FitViz. The PT will review the progress with participants via 20-minute bi-weekly phone calls, and progressively modify their activities. In Month 3, participants will continue using the Fitbit/FitViz and have access to a PT via email as needed, but no bi-weekly phone calls. In Months 4-9, participants may continue using the Fitbit/FitViz without access to a PT.
Group II: Delayed Intervention GroupPlacebo Group1 Intervention
Same intervention with a 3 month delay: The full intervention will be initiated in Month 4 and with a brief education session, use of a Fitbit Flex paired with the FitViz app, and counseling by a physiotherapist. In Months 6-9, participants will continue using Fitbit/FitViz without the PT phone calls.

Find a Location

Who is running the clinical trial?

Fraser HealthOTHER
46 Previous Clinical Trials
707,530 Total Patients Enrolled
Arthritis Research Centre of CanadaOTHER
14 Previous Clinical Trials
13,790 Total Patients Enrolled
Simon Fraser UniversityOTHER
57 Previous Clinical Trials
10,628 Total Patients Enrolled
~7 spots leftby Nov 2025